Expanded Indications for GLP-1 Receptor Agonists The 2025 American Diabetes Association (ADA) Standards of Care have broadened the use of GLP-1 receptor agonists beyond glycemic control
so far i have not had any nausea
GLP-1 and dual agonist therapies such as Wegovy, Ozempic, Saxenda, Mounjaro, and ZepBound are titrated slowly to prevent gastrointestinal discomfort and allow the body to adapt to changes in gastric emptying
More recent research using advanced delivery systems achieved even more impressive results, with ionic liquid microemulsion formulations driving faster anagen entry than standard GHK-Cu or minoxidil
The second half of the presentation will review the FDA approved indications for GLP-1 medications and outline the potential use of GLP-1 medications to treat patients with conditions including Bulimia Nervosa and Binge Eating Disorder
It could also mean you need to adjust your diet and exercise habits, or that your body has hit a temporary plateau